Oncolys Biopharma Inc
TSE:4588
Oncolys Biopharma Inc
Cash from Investing Activities
Oncolys Biopharma Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
O
|
Oncolys Biopharma Inc
TSE:4588
|
Cash from Investing Activities
-¥5.4m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
GNI Group Ltd
TSE:2160
|
Cash from Investing Activities
-¥6.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-42%
|
|
PeptiDream Inc
TSE:4587
|
Cash from Investing Activities
¥1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Cash from Investing Activities
-¥8.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
5%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash from Investing Activities
¥1B
|
CAGR 3-Years
101%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
S
|
StemRIM Inc
TSE:4599
|
Cash from Investing Activities
-¥344k
|
CAGR 3-Years
87%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Oncolys Biopharma Inc's Cash from Investing Activities?
Cash from Investing Activities
-5.4m
JPY
Based on the financial report for Dec 31, 2023, Oncolys Biopharma Inc's Cash from Investing Activities amounts to -5.4m JPY.
What is Oncolys Biopharma Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
48%
The average annual Cash from Investing Activities growth rates for Oncolys Biopharma Inc have been 48% over the past three years .